The acquired resistance of cancer cells to TNF-induced cell death is currently a research area of interest, as modulators of the TNF/TNFR1 signalling pathway have the potential to sensitise resistant cancer cells to TNF [240, 242]. The gene discussed is TNFRSF1A; the disease is cancer.